Moderna Inc. Stock Advances 7.0%, Outperforms Peers
Dow Jones2026/09/24 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. rose 7.0% to $194.82 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 26,939.37 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.
Moderna Inc. hit a new 52-week high, surpassing its previous peak of $192.31, which the company reached on September 23rd.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.6% to $270.68, Pfizer Inc. rose 0.8% to $28.41, and Gilead Sciences Inc. fell 1.11% to $149.69.
Trading volume totaled 16.4 million, compared to the 50-day average of 18.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 24, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
